SI-BONE, Inc. (SIBN) intrinsic value & 10-year financials
SI-BONE, Inc. (SIBN) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 19.6% a year to $200.9M, with an average return on invested capital of 5.2%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $19.68
- Market cap
- $845.4M
- Revenue (FY2025)
- $200.9M
- Revenue growth (10-yr CAGR)
- 19.6%
- ROIC (10-yr avg)
- 5.2%
- Free cash flow (FY2025)
- -$9.1M
SIBN 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $200.9M | -$18.9M | -$0.44 | -$9.1M | -11.1% | -13.2% |
| FY2024 | $167.2M | -$30.9M | -$0.75 | -$22.9M | -21.1% | -20.6% |
| FY2023 | $138.9M | -$43.3M | -$1.13 | -$26.5M | -33.8% | -32.4% |
| FY2022 | $106.4M | -$61.3M | -$1.79 | -$51.2M | -56.0% | -52.8% |
| FY2021 | $90.2M | -$56.6M | -$1.71 | -$45.9M | -57.3% | -38.9% |
| FY2020 | $73.4M | -$43.7M | -$1.50 | -$33.2M | -52.6% | -35.4% |
| FY2019 | $67.3M | -$38.4M | — | -$34.1M | -53.5% | -39.2% |
| FY2018 | $55.4M | -$17.5M | — | -$15.5M | -21.6% | 264.5% |
| FY2017 | $48.0M | -$23.0M | — | -$18.0M | -36.2% | 15.3% |
| FY2016 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
SI-BONE, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
SI-BONE, Inc. has historically struggled to out-earn its cost of capital, averaging just -23.8% ROIC.
SI-BONE, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, SI-BONE, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-14.61 per share.